EUVIMEDEUVIMED entdecken
Editorial

Inflammation and atherogenic particle burden: Joint risk without proven synergy

Allan D Sniderman, Kevin C Maki

Progress in Cardiovascular Diseases · 2026-09

DOI: 10.1016/j.pcad.2026.09.007 ↗

Kurz gefasst

Editorial in der Zeitschrift Progress in Cardiovascular Diseases, 2026-09. Verfasst von Allan D Sniderman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre 1001 Decarie Blvd., Montrea…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre 1001 Decarie Blvd., Montreal, Quebec H4A 3J1, Canada.
  • Midwest Biomedical Research, Addison, IL 60101, USA; Department of Applied Health Science, Indiana University School of Public Health-Bloomington, Bloomington, IN 47405, USA. Electronic address: kmaki@mbclinicalresearch…

Zitieren

APA

Sniderman, A. D., & Maki, K. C. (2026). Inflammation and atherogenic particle burden: Joint risk without proven synergy. Progress in Cardiovascular Diseases. https://doi.org/10.1016/j.pcad.2026.09.007

Vancouver

Sniderman AD, Maki KC. Inflammation and atherogenic particle burden: Joint risk without proven synergy. Progress in Cardiovascular Diseases. 2026. doi:10.1016/j.pcad.2026.09.007

BibTeX
@article{Sniderman2026,
  author = {Sniderman, Allan D and Maki, Kevin C},
  title = {Inflammation and atherogenic particle burden: Joint risk without proven synergy},
  journal = {Progress in Cardiovascular Diseases},
  year = {2026},
  doi = {10.1016/j.pcad.2026.09.007}
}
Kostenlos starten →